Bolt Biotherapeutics, Inc. - 10-Q Filing
Bolt Biotherapeutics filed its quarterly report for the period ended March 31, 2026. The filing includes financial data and disclosures related to fair value measurements of various securities such as U.S. Treasury securities, corporate debt, commercial paper, money market funds, and asset-backed securities.
Tickers: $BOLT